Abiopharma

Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting

Allient Inc. Elects Alex Collichio as Vice President

FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus

Duos Technologies Group Sets First Quarter 2026 Earnings Call for Monday, May 18, 2026 at 8:30 AM ET

Axe Compute to Host Q1 2026 Financial Results Conference Call

SoundThinking Honors Law Enforcement During National Police Week 2026

ARRAY Technologies to Participate in Upcoming Investor Conferences

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

Director Thompson Jeffrey M 🟡 adjusted position in 1.1M shares (3 derivative) of Red Cat Holdings, Inc. (RCAT) at $13.06 ($13.6M) Transaction Date: Apr 06, 2026 | Filing ID: 022145

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001213900-26-054293 <b>Size:</b> 2 MB

Amex Exploration annonce un placement privé sursouscrit de 43,5 millions $ CA et un placement privé concomitant additionnel jusqu’à concurrence de 31 millions $ CA

Amex Exploration Announces Oversubscribed C$43.5 Million LIFE Offering and Additional Concurrent Private Placement of Up to C$31 Million

New Form 3 - Atmus Filtration Technologies Inc. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001921963-26-000049 <b>Size:</b> 3 KB

(99% Neutral) AMERICAN ASSETS TRUST, INC. (AAT) Announces Business Combination

(99% Neutral) PAR PACIFIC HOLDINGS, INC. (PARR) Files Form 8-K